The case for newborn screening for congenital adrenal hyperplasia in Australia

Garry L. Warne, Katrina L. Armstrong, Thomas A. Faunce, Bridget M. Wilcken, Avihu Boneh, Elizabeth Geelhoed, Maria E. Craig

Research output: Contribution to journalLetterpeer-review

12 Citations (Scopus)

Abstract

We write to encourage policy debate over newborn screening for congenital adrenal hyperplasia (CAH). Classical CAH is a severe, life-threatening disease affecting about one in 15 000 liveborn infants in Australia.1 An inexpensive screening test for newborns is available, but this test is not included in the current newborn screening program in Australia.
Original languageEnglish
Pages (from-to)107
Number of pages1
JournalMedical Journal of Australia
Volume192
Issue number2
DOIs
Publication statusPublished - 18 Jan 2010

Fingerprint

Dive into the research topics of 'The case for newborn screening for congenital adrenal hyperplasia in Australia'. Together they form a unique fingerprint.

Cite this